Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Migraine Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Migraine Pipeline Highlights…
DUBLIN–(BUSINESS WIRE)–The “Global Mesothelioma Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Mesothelioma Pipeline Highlights…
DUBLIN–(BUSINESS WIRE)–The “Global Peripheral Vascular Disease Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Peripheral…
DUBLIN–(BUSINESS WIRE)–The “Global Methicillin Resistant Staphylococcus Aureus Infections Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Global Neuroblastoma Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Neuroblastoma Pipeline Highlights…
DUBLIN–(BUSINESS WIRE)–The “Global Retinitis Pigmentosa Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Retinitis Pigmentosa…
DUBLIN–(BUSINESS WIRE)–The “Global Wound Closure Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Wound Closure…
DUBLIN–(BUSINESS WIRE)–The “Global Psoriatic Arthritis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Psoriatic Arthritis…
DUBLIN–(BUSINESS WIRE)–The “Global Thrombosis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Thrombosis Pipeline Highlights…
LEXINGTON, Mass.–(BUSINESS WIRE)–#GBMAGILE–Jeffrey Tarrant, entrepreneur, hedge fund investor, philanthropist, and brain cancer survivor, has agreed to join the Board of…